Journals / Respiratory Case Reports / 2015 / Cilt: 4 - Sayı: 3

Vitamin D and Fatigue; in a Case with Tuberculosis

D Vitamini ve Yorgunluk; Bir Tüberküloz Olgusunda

Pages
151–155
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We believe that the assessment of fatigue, which is usually un- derestimated by patients and healthcare professionals a like, is probably due to the lack of any attempt to measure it, but would contribute to the evaluation of the treatment response.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vitamin D is converted into its active metabolites by sunlight.
📊
Key Findings & Data:Several illnesses may occur when the serum level of Vitamin D is decreased.
💡
Conclusion & Impact:We believe that the assessment of fatigue, which is usually un- derestimated by patients and healthcare professionals a like, is probably due to the lack of any attempt to measure it, but would contribute to the evaluation of the treatment response.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Vitamin D is converted into its active metabolites by sunlight. Several illnesses may occur when the serum level of Vitamin D is decreased. The association be- tween tuberculosis and sunlight has been known for hundreds of years, and sunlight was the first method used for the treatment of tuberculosis. Fatigue is often an early complaint of Vitamin D deficiency. We found Vitamin D deficiency in one patient who was initiated on an anti-tuberculosis treatment following a diagno- sis of tuberculosis on her persistent complaint of fatigue. The Severity of Fatigue Scale was used to evaluate pre- and post-treatment fatigue scores for Vitamin D therapy, indicating an improvement in the severity of fatigue following the treatment. We believe that the assessment of fatigue, which is usually un- derestimated by patients and healthcare professionals a like, is probably due to the lack of any attempt to measure it, but would contribute to the evaluation of the treatment response.

Özet

D vitamini aktif metabolitlerine güneş ışığı ile dönü- şür. D vitamini serum düzeyinin azaldığı durumlarda çeşitli hastalıklar ortaya çıkabilir. Tüberküloz ile güneş ışığı arasındaki ilişki yüzyıllardır fark edilmiştir ve tüberkülozda kullanılan ilk tedavi yöntemi olmuştur. D vitamini eksikliğinde yorgunluk genellikle ilk şikâyettir. Tüberküloz tanısı ile antitüberküloz tedavi başlanan ancak yorgunluk şikâyeti devam eden hastamızda D vitamini eksikliği tesbit edildi. Yorgunluk Şiddet Skala- sı, D vitamini tedavisi öncesi ve sonrası hesaplandı ve tedavi sonrası yorgunluk şiddetinin azaldığı görüldü. Hastalar ve hekimler tarafından genellikle gözardı edilen yorgunluk semptomunun ölçülmesinin tedaviye cevabının değerlendirilmesine katkı sağlayacağına inanıyoruz.

🔖

Cite This Article

MERMİT, B. Ç. (2015). Vitamin D and Fatigue; in a Case with Tuberculosis. Respiratory Case Reports, Cilt: 4 - Sayı: 3, 151–155. https://ajindex.com/articles/302523

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Global tuberculosis control: WHO report 2011. Geneva, World Health Organization, 2011 (WHO/HTM/TB/2011.16)
  2. Sağlık Bakanlığı Verem Savaşı Dairesi Başkanlığı. Türkiye'de Verem Savaşı, 2011 Raporu, Fersat Ofset, Ankara 2011
  3. Holick MF. Vitamin D Deficiency. N Engl J Med 2007; 357:266-81. [CrossRef] 4. Brown RH, JR, Amato AA, Mendell JR. Muscular dystrophies and other muscle diseases. In: Fauci AS, Braunwald E, Kasper DL, eds. Harrison's Principles of Internal Medicine. New York: McGraw Hill Medical; 2008:2678-95
  4. Wingfield T, Schumacher SG, Sandhu G, Tovar MA, Zevallos K, Baldwin MR, et al. The seasonality of tuberculosis, sunlight, vitamin D, and household crowding. J Infect Dis. 2014; 210:774-83. [CrossRef] 6. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik S, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-3. [CrossRef] 7. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D- mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007; 179:2060-3. [CrossRef] 8. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998; 351:805-6. [CrossRef] 9. Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asian in west London: a case control study. Lancet 2000; 355:618-21. [CrossRef] 10. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006; 38:3-5
  5. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911-30. [CrossRef] 12. Comi G, Leocani L, Rossi P, Colombo B. Physiopathology and treatment of fatigue in multiple sclerosis. J Neurol 2001; 248:174-9. [CrossRef] 13. Armutlu K, Korkmaz NC, Keser I, Sumbuloglu V, Akbiyik DI, Guney Z, et al. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res 2007; 30:81-5. [CrossRef] 14. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46:11